One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Dermatology and venereology – highlights in research and patient care in 2021
J. Ring
doi : 10.1111/jdv.17822
Volume 36, Issue 1 p. 8-10
New important data on the transmission of cutaneous human papillomaviruses
A. Kreuter,U. Wieland
doi : 10.1111/jdv.17820
Volume 36, Issue 1 p. 11-12
Learning from itch – epidermolysis bullosa is a genetically determined barrier disruption and a chronic inflammatory disease
Z. Ruszczak,S. Abdelhadi
doi : 10.1111/jdv.17821
Volume 36, Issue 1 p. 13-16
Pioneers in Dermatology and Venereology: An Interview with Professor Danilo V. Stevanovic
D.V. Stevanovic
doi : 10.1111/jdv.17819
Volume 36, Issue 1 p. 17-19
Quality of life assessment in core outcome sets: A position statement of the EADV Task Force on Quality of Life and Patient Oriented Outcomes
P.V. Chernyshov,A.W.M. Evers,A. Bewley,L. Tomas-Aragones,S.E. Marron,L. Manolache,N. Pustišek,D. Abeni,F. Sampogna,M.D. Linder,M.S. Salek,J.C. Szepietowski
doi : 10.1111/jdv.17725
Volume 36, Issue 1 p. 20-23
Core outcome sets (COSs) are an agreed standardized collection of outcomes that should be measured and reported in all clinical trials for a specific clinical condition. Tsekhe aim of our position paper by the European Academy of Dermatology and Venereology (EADV) Task Force on Quality of Life and Patient Oriented Outcomes was to identify the challenges and Patient Oriented Outcomes advantages in the development of COSs within dermatological QoL research. Twelve EADV Task Force multidisciplinary team members presented a total of 101 items (51 advantages and 50 disadvantages). All participants considered that COS are beneficial for comparison between different studies, treatments, dermatological diseases, geographical location and ethnicities. In conclusion, the EADV Task Force on Quality of Life and Patient Oriented Outcomes has recognized the primacy of advantages of COS and deliberated that the disadvantages in COS are related to development process and use of COS.
Are the chilblain-like lesions observed during the COVID-19 pandemic due to severe acute respiratory syndrome coronavirus 2? Systematic review and meta-analysis
V. Sánchez-García,R. Hernández-Quiles,E. de-Miguel-Balsa,A. Docampo-Simón,I. Belinchón-Romero,J.M. Ramos-Rincón
doi : 10.1111/jdv.17672
Volume 36, Issue 1 p. 24-38
The expansion of the COVID-19 pandemic has been accompanied by numerous reports of chilblain-like lesions (CLL) in different countries; however, the pathogenesis of these lesions is still unclear. This systematic review and meta-analysis aimed to assess the prevalence of COVID-19 (diagnosed using PCR and/or serology) in patients with CLL. We undertook a literature search in PubMed, Embase, and Scopus (to 15 March 2021), including studies that reported on the number of patients with CLL with positive PCR and/or serology for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or with a clinical suspicion of COVID-19. Regardless of data heterogeneity, a random-effects model was used to pool prevalence estimates. The meta-analysis included 63 original studies, involving 2919 cases of CLL. A subgroup of these patients underwent diagnostic tests for COVID-19 (PCR: n?=?1154, 39.5%; serology: n?=?943, 32.3%). The pooled prevalence of COVID-19 in the overall sample and in the subgroup who were tested for COVID-19 was, respectively: (i) positive PCR: 2.6% [95% confidence interval (CI) 1.9% to 3.4%] and 5.5% (95% CI, 3.7–7.7%); (ii) positive serology for SARS-CoV-2: 7.2% (95% CI, 4.7–10.2%) and 11.8% (95% CI, 7.9–16.3%); and (iii) positive PCR and/or serology, 15.2% (95% CI, 10.4–20.7%) and 7.5% (95% CI, 5.1–10.3%). Altogether, a small proportion of diagnostic tests for SARS-CoV-2, both PCR and serologies, show positive results in patients with CLL.
Epidemiology of advanced cutaneous squamous cell carcinoma
C. Dessinioti,M. Pitoulias,A. J. Stratigos
doi : 10.1111/jdv.17709
Volume 36, Issue 1 p. 39-50
Cutaneous invasive squamous cell carcinoma (cSCC) most commonly presents as a typically indolent tumour with five-year cure rates of >90%. Advanced cSCC has been defined as locally advanced or metastatic (locoregional or distant) cSCC. The epidemiological data on advanced cSCC are rare due to underreporting or exclusion of cSCC from national cancer registries. Although the frequency of local recurrence has been reported, there is no clear evidence on the incidence or mortality of locally advanced cSCCs, e.g. locally infiltrating or locally recurrent cSCCs that are not further amenable to curative surgery or radiotherapy. This gap of knowledge on the epidemiology of locally advanced cSCC, highlights the need for standardisation in defining and reporting both locally advanced and metastatic cSCC. Even though metastatic cSCCs are a small part of cSCCs (3%–5%), their aggressive characteristics contribute to significant morbidity, higher mortality and are those likely to require systemic treatments. Locally recurrent and metastatic cSCC may occur more frequently in high-risk cSCCs (up to 35%). The site of metastasis involves in the vast majority the regional lymph nodes, with the head and neck lymph nodes or parotid most commonly affected. Metastasis occurs mostly within 2–3?years of the primary cSCC diagnosis. The knowledge of the incidence and prognosis of advanced cSCC and the risk stratification of patients, who may progress to advanced cSCC, emerge as pressing research areas with important implications for cost-efficiency planning and optimisation of patient care.
Bifocal 532/1064?nm alternately illuminated photoacoustic microscopy for capturing deep vascular morphology in human skin
Z. Wang,F. Yang,H. Ma,Z. Cheng,W. Zhang,K. Xiong,T. Shen,S. Yang
doi : 10.1111/jdv.17677
Volume 36, Issue 1 p. 51-59
As a promising technology, photoacoustic microscopy (PAM) plays a critical role in diagnosis and assessment of dermatological conditions by providing subtle vascular networks non-invasively. However, the established PAMs are insufficient for clinical dermatology when faced with complex structures of human skin instead of animal models owing to high melanin content and superimposed vasculature for Asians, which cannot balance the spatial resolution and the imaging depth.
Quality of life and patient-perceived symptoms in patients with psoriasis undergoing proactive or reactive management with the fixed-dose combination Cal/BD foam: A post-hoc analysis of PSO-LONG
A. Jalili,P. Calzavara-Pinton,L. Kircik,D. Lons-Danic,A. Pink,S. Tyring,P. de la Cueva,M. Gooderham,S. Segaert,N. Nyholm,H. Thoning,B. Petersen,D. Thaçi
doi : 10.1111/jdv.17673
Volume 36, Issue 1 p. 60-67
Psoriasis has important physical and psychosocial effects that extend beyond the skin. Understanding the impact of treatment on health-related quality of life (HRQoL) and patient-perceived symptom severity in psoriasis is key to clinical decision-making.
Image-based automated Psoriasis Area Severity Index scoring by Convolutional Neural Networks
M.J. Schaap,N.J. Cardozo,A. Patel,E.M.G.J. de Jong,B. van Ginneken,M.M.B. Seyger
doi : 10.1111/jdv.17711
Volume 36, Issue 1 p. 68-75
The Psoriasis Area and Severity Index (PASI) score is commonly used in clinical practice and research to monitor disease severity and determine treatment efficacy. Automating the PASI score with deep learning algorithms, like Convolutional Neural Networks (CNNs), could enable objective and efficient PASI scoring.
Effects of an emollient application on newborn skin from birth for prevention of atopic dermatitis: a randomized controlled study in Thai neonates
L. Techasatian,P. Kiatchoosakun
doi : 10.1111/jdv.17675
Volume 36, Issue 1 p. 76-83
Enhancing the skin barrier in high-risk neonates by daily use of emollients during infancy might prevent atopic dermatitis (AD); however, there have been no studies on this topic in a country with a tropical climate. Climate may affect the results of the use of emollients in neonates for AD prevention and possible adverse cutaneous eruptions.
Addictions in patients with atopic dermatitis: a cross-sectional pilot study in Germany
A.C. Pilz,V. Durner,M.C. Schielein,B. Schuster,J. Beckmann,T. Biedermann,K. Eyerich,A. Zink
doi : 10.1111/jdv.17708
Volume 36, Issue 1 p. 84-90
Atopic dermatitis (AD) is the most common chronic inflammatory skin disease worldwide and displays many atopic, but also non-atopic comorbidities. Among the latter, mental health disorders such as depression have been extensively studied. However, data on addictions are still rare.
Epidemiology, comorbidities, and healthcare utilization of patients with chronic urticaria in Germany
K. Weller,M. Maurer,A. Bauer,B. Wedi,N. Wagner,S. Schliemann,T. Kramps,D. Baeumer,J. Multmeier,E. Hillmann,P. Staubach
doi : 10.1111/jdv.17724
Volume 36, Issue 1 p. 91-99
Comprehensive data on the epidemiology and comorbidities of chronic urticaria (CU) in Germany are either limited, or not contemporary.
Cutaneous manifestations of small fibre polyneuropathy
A.L. Akabane,G.P. Smith
doi : 10.1111/jdv.17714
Volume 36, Issue 1 p. 100-107
Because typical and atypical features of small fibre polyneuropathy (SFN) in the skin have not been fully elucidated, the diagnosis is often made by the exclusion of alternative conditions rather than by its identification as a primary syndrome.
A single-arm pilot of a web-based intervention to improve itch-related quality of life
C.J. Heckman,M. Riley,Z. Niu,S.-E. Lu,R. Valdes-Rodriguez,G. Yosipovitch
doi : 10.1111/jdv.17686
Volume 36, Issue 1 p. 108-112
Many patients with chronic itch and atopic dermatitis (AD) or psoriasis do not receive/use available medical and psychosocial treatments properly due to system, provider and/or patient factors.
Sexually transmitted infections epidemiology and risk assessment at the main correctional facility in Malta (2017–2019)
K. Muscat,C. Cremona,T. Melillo Fenech,M. Abela,V. Padovese
doi : 10.1111/jdv.17681
Volume 36, Issue 1 p. 113-118
Inmates suffer from mental and physical ailments combined with substance misuse and addiction which are often underreported or disregarded by sufferers, for fear of being stigmatized. This vulnerable group has complex medical and psychosocial needs and hence gathering data is essential for a holistic approach to care.
HPV type-specific distribution among family members and linen in households of cutaneous wart patients
E. Ghorzang,M.N.C. de Koning,J.N. Bouwes Bavinck,J. Gussekloo,K.D. Quint,J.J. Goeman,M.C.W. Feltkamp,S.C. Bruggink,J.A.H. Eekhof
doi : 10.1111/jdv.17684
Volume 36, Issue 1 p. 119-125
Common and plantar warts are caused by human papillomaviruses (HPV). Mode of transmission of wart HPVs within families is largely unknown.
Risk factors for scabies treatment resistance: a retrospective cohort study
S.K. Lee,J.H. Kim,M.S. Kim,U.H. Lee
doi : 10.1111/jdv.17713
Volume 36, Issue 1 p. 126-132
In order to successfully treat scabies and to prevent its spread, it is important to identify the factors that can influence the outcome of scabies treatment.
Dystrophic epidermolysis bullosa pruriginosa: a new case series of a rare phenotype unveils skewed Th2 immunity
D. Darbord,G. Hickman,N. Pironon,C. Barbieux,M. Bonnet-des-Claustres,M. Titeux,S. Miskinyte,F. Cordoliani,M.D. Vignon-Pennamen,R. Amode,A. Hovnanian,E. Bourrat
doi : 10.1111/jdv.17671
Volume 36, Issue 1 p. 133-143
Dystrophic epidermolysis bullosa pruriginosa (DEB-Pr) is a rare subtype of hereditary epidermolysis bullosa, with a poorly understood pathogenesis and no satisfactory treatment.
Epigallocatechin-3-gallate exhibits anti-inflammatory effects in a human interface dermatitis model—implications for therapy
C. Braegelmann,D. Niebel,S. Ferring-Schmitt,T. Fetter,J. Landsberg,M. Hölzel,M. Effern,N. Glodde,S. Steinbuch,T. Bieber,J. Wenzel
doi : 10.1111/jdv.17710
Volume 36, Issue 1 p. 144-153
Epigallocatechin-3-gallate (EGCG) has been proven effective in treating viral warts. Since anticarcinogenic as well as anti-inflammatory properties are ascribed to the substance, its use has been evaluated in the context of different dermatoses. The effect of EGCG on interface dermatitis (ID), however, has not yet been explored.
Dermoscopy in General Dermatology for Skin of Color by Errichetti and Lallas, 2021; 226 pp. ISBN 9780367418403. Price EUR 165,00
G. Argenziano
doi : 10.1111/jdv.17823
Volume 36, Issue 1 p. 154-154
COVID-19 and skin diseases: results from a survey of 843 patients with atopic dermatitis, psoriasis, vitiligo and chronic urticaria
P.R. Criado,M. Ianhez,C.C. Silva de Castro,C. Talhari,P.M. Ramos,H.A. Miot
doi : 10.1111/jdv.17635
Volume 36, Issue 1 p. e1-e3
Changes in the incidence of contagious infectious skin diseases after the COVID-19 outbreak
E.J. Chun,J.K. Kim,S.Y. Yang,S.S. Kim,C.W. Kim
doi : 10.1111/jdv.17640
Volume 36, Issue 1 p. e3-e4
Erythema annulare centrifugum triggered by SARS-CoV-2 infection
N. Setó-Torrent,A. Altemir,M. Iglesias-Sancho,M.T. Fernández-Figueras
doi : 10.1111/jdv.17645
Volume 36, Issue 1 p. e4-e6
Varicella-zoster and herpes simplex virus reactivation post-COVID-19 vaccination: a review of 40 cases in an International Dermatology Registry
R.A. Fathy,D.E. McMahon,C. Lee,G.C. Chamberlin,M. Rosenbach,J.B. Lipoff,A. Tyagi,S.R. Desai,L.E. French,H.W. Lim,B.H. Thiers,G.J. Hruza,M. Fassett,L.P. Fox,H.L. Greenberg,K. Blumenthal,E.E. Freeman
doi : 10.1111/jdv.17646
Volume 36, Issue 1 p. e6-e9
Two cases of pityriasis rosea after the injection of coronavirus disease 2019 vaccine
L. Huang,Z. Yao,J. Zhang
doi : 10.1111/jdv.17648
Volume 36, Issue 1 p. e9-e11
Reply to “Psoriasis exacerbation after COVID-19 vaccination: report of 14 cases from a single centre” by Sotiriou E et al.
M. Megna,L. Potestio,L. Gallo,G. Caiazzo,A. Ruggiero,G. Fabbrocini
doi : 10.1111/jdv.17665
Volume 36, Issue 1 p. e11-e13
A case of bullous pemphigoid after the SARS-CoV-2 mRNA vaccine
J. Young,L. Mercieca,M. Ceci,D. Pisani,A. Betts,M.J. Boffa
doi : 10.1111/jdv.17676
Volume 36, Issue 1 p. e13-e16
Erythema nodosum, zoster duplex and pityriasis rosea as possible cutaneous adverse effects of Oxford–AstraZeneca COVID-19 vaccine: report of three cases from India
H. Mehta,S. Handa,P. Malhotra,M. Patial,S. Gupta,A. Mukherjee,D. Chatterjee,A. Takkar,R. Mahajan
doi : 10.1111/jdv.17678
Volume 36, Issue 1 p. e16-e18
Personal protective equipment use and face acne in health care providers during the COVID-19 pandemic in Romania: A new occupational acne type?
S. Cretu,M. Dascalu,S.R. Georgescu,C.M. Salavastru
doi : 10.1111/jdv.17679
Volume 36, Issue 1 p. e18-e20
SARS-CoV-2 mRNA vaccine injection site pseudolymphoma
D. Mintoff,L. Scerri,A. Betts
doi : 10.1111/jdv.17680
Volume 36, Issue 1 p. e20-e22
Pfizer-BioNTech SARS-CoV-2 mRNA vaccine-associated erythema multiforme
L. Borg,L. Mercieca,D. Mintoff,D. Micallef,D. Pisani,A. Betts,L. Scerri
doi : 10.1111/jdv.17682
Volume 36, Issue 1 p. e22-e24
Early atypical injection-site reactions to COVID-19 vaccine: a case series
M. Vaccaro,L. Bertino,R. Squeri,C. Genovese,S. Isola,G. Spatari,E. Spina,P. Cutroneo
doi : 10.1111/jdv.17683
Volume 36, Issue 1 p. e24-e26
Eosinophilic cellulitis after BNT162b2 mRNA Covid-19 vaccine
L. de Montjoye,L. Marot,M. Baeck
doi : 10.1111/jdv.17685
Volume 36, Issue 1 p. e26-e28
COVID vaccine-induced lichen planus on areas previously affected by vitiligo
V. Piccolo,C. Mazzatenta,A. Bassi,G. Argenziano,M. Cutrone,R. Grimalt,T. Russo
doi : 10.1111/jdv.17687
Volume 36, Issue 1 p. e28-e30
Nevocentric erythema multiforme after SARS-COV-2 vaccine
C. Scharf,E.V. Di Brizzi,S. Pellerone,M. Liguori,C.M.R. Giorgio,G. Argenziano
doi : 10.1111/jdv.17688
Volume 36, Issue 1 p. e30-e32
Erythema multiforme after SARS-CoV-2 vaccine
L.-w. Zhang,W.-j. Wang,C.-h. Li,T. Chen
doi : 10.1111/jdv.17689
Volume 36, Issue 1 p. e32-e33
Flagellate purpura associated with COVID-19 vaccination
E. Heck,B.D. Rankin,M. Schneider,V.H. Prajapati
doi : 10.1111/jdv.17609
Volume 36, Issue 1 p. e33-e34
Incomplete Mohs surgery: a long-term, nationwide prospective cohort to describe recurrence rate and risk factors (REGESMOHS, Spanish Registry of Mohs Surgery)
M. Oro-Ayude,B. González-Sixto,O. Sanmartin-Jiménez,J.R. Garcés,M.A. Rodríguez-Prieto,V. Ruiz-Salas,E. de Eusebio-Murillo,R. Miñano-Medrano,B. Escutia-Muñoz,C. Feal Cortizas,J.L. Artola-Igarza,A. Alfaro-Rubio,P. Redondo,Y. Delgado-Jiménez,J.M. Sánchez-Schmidt,I. Allende-Markixana,M.L. Alonso-Pacheco,B. García-Bracamonte,P. de la Cueva-Dobao,R. Navarro-Tejedor,C. Ciudad-Blanco,L. Carnero-González,H. Vázquez-Veiga,N. Cano-Martínez,E. Vilarrasa-Rull,P. Sánchez-Sambucety,J.L. López-Estebaranz,R. Botella-Estrada,A. Martorell-Calatayud,P. Gil,V. Morales-Gordillo,A. Toll-Abelló,I. Ocerin-Guerra,M. Mayor-Arenal,R. Suárez-Fernández,L. Sainz-Gaspar,M.A. Descalzo,I. Garcia-Doval,Á. Flórez,REGESMOHS (Registro Español de Cirugía de Mohs)
doi : 10.1111/jdv.17597
Volume 36, Issue 1 p. e35-e37
Line-field confocal optical coherence tomography of pyogenic granulomas in children: report of two cases
C. Gallay,S. Ventéjou,S. Christen-Zaech
doi : 10.1111/jdv.17608
Volume 36, Issue 1 p. e37-e39
Successful treatment of calcinosis cutis with a topical sodium thiosulphate preparation containing 20% zinc oxide in a patient with sclerotic graft-versus-host disease
C. Müller,A. Tanew,G. Laml-Wallner,S. Radakovic
doi : 10.1111/jdv.17610
Volume 36, Issue 1 p. e39-e41
Patient preferences for curettage followed by imiquimod 5% cream vs. surgical excision for the treatment of non-facial nodular basal cell carcinoma: a discrete choice experiment
K.A.E. Sinx,K. Mosterd,D. de Coster,B.A. Essers
doi : 10.1111/jdv.17611
Volume 36, Issue 1 p. e41-e43
Restoration of collagen and elastic fibre networks following treatment of photoaged skin with Serènesse, a novel over-the-counter anti-ageing product
A.K. Langton,J.C. McConnell,L.F. Cotterell,P. Halai,T.W. Griffiths,C.E.M. Griffiths,R.E.B. Watson
doi : 10.1111/jdv.17612
Volume 36, Issue 1 p. e43-e46
Real-world data on pain management and effectiveness of anti-tumour necrosis factor agents in refractory livedoid vasculopathy
Y. Gao,H. Jin
doi : 10.1111/jdv.17613
Volume 36, Issue 1 p. e46-e48
Acute haemorrhagic oedema-like eruption in an adult
A. De Greef,C. Dachelet,L. Marot,M. Baeck
doi : 10.1111/jdv.17617
Volume 36, Issue 1 p. e48-e50
The role of genetic factors and peripheral immune cells in SAPHO syndrome
G. Ge,B. Xie,Z. Chen,W. Zhang,H. Jiang,X. Yu,X. Sang,H. Wang
doi : 10.1111/jdv.17618
Volume 36, Issue 1 p. e50-e52
Successful treatment of disseminated superficial actinic porokeratosis with topical 2% cholesterol/ 2% lovastatin cream: a case series with 7 patients
D. Tomsitz,T. Biedermann
doi : 10.1111/jdv.17619
Volume 36, Issue 1 p. e52-e54
Novel ADAR1 mutations in three cases of psoriasis coexisting with dyschromatosis symmetrica hereditaria
H.-Y. Weng,R.-W. Wu,Y.-T. Chen,Y.-F. Lin,Y.-M. Liu,S.-F. Tsai,C.-H. Chang
doi : 10.1111/jdv.17620
Volume 36, Issue 1 p. e54-e57
Difference in health-related quality of life between anxiety and depressive symptoms in Japanese patients with plaque psoriasis: the ProLOGUE study
C. Ohata,Y. Kanai,K. Murotani,H. Kitabayashi,S. Imafuku
doi : 10.1111/jdv.17621
Volume 36, Issue 1 p. e57-e59
Reflectance confocal microscopy features of uncommon histopathological variants of cutaneous melanoma
M. Lai,R. Pampena,S. Piana,G. Pellacani,C. Longo
doi : 10.1111/jdv.17622
Volume 36, Issue 1 p. e60-e62
Sublingual minoxidil for the treatment of male and female pattern hair loss: a randomized, double-blind, placebo-controlled, phase 1B clinical trial
L. Bokhari,L.N. Jones,R.D. Sinclair
doi : 10.1111/jdv.17623
Volume 36, Issue 1 p. e62-e66
LC-MS/MS and immuno-electron subtyping combined with genetics show that OSMR mutations cause amyloid deposition of keratins 5/14 in familial primary localized cutaneous amyloidosis
R. Bourguiba,C. Bachmeyer,P. Moguelet,S. Kaaki,C. Ory,G. Touchard,E. Cattan,S. Georgin-Lavialle,M. Colombat,S. Valleix
doi : 10.1111/jdv.17630
Volume 36, Issue 1 p. e66-e68
Penile nodules as a manifestation of lymphogranuloma venereum: an underrecognized form
J. Riera-Monroig,F. Alamon-Reig,P. Giavedoni,Y. Zboromyrska,N. Castrejón,A. García-Herrera,I. Fuertes
doi : 10.1111/jdv.17634
Volume 36, Issue 1 p. e69-e70
Development and validation of an outcome instrument measuring dry skin – the Xerosis Area and Severity Index (XASI)
R. Sommer,M. Augustin,N. da Silva,C.C. von Stülpnagel
doi : 10.1111/jdv.17636
Volume 36, Issue 1 p. e70-e72
Cutaneous complications after tattooing in Finland from 2016 to 2021
N. Kluger
doi : 10.1111/jdv.17637
Volume 36, Issue 1 p. e72-e73
Evaluation of the effects on cutaneous sensitivity of a face emulsion containing sclareolide in women presenting with sensitive skin through quantitative sensory testing
M. Peres,F. Huet,M. Le Bonniec,S. Guéhenneux,K. Vié,L. Misery
doi : 10.1111/jdv.17638
Volume 36, Issue 1 p. e74-e75
Radiotherapy-induced subclinical skin changes revealed by dynamic optical coherence tomography: a case-controlled pilot study
C. Chello,S. Ciardo,J. Chester,M. Guanti,F. Farnetani,S. Guida,A. Sticchi,P. Giacobazzi,B. Meduri,F. Lohr,G. Pellacani,M. Manfredini
doi : 10.1111/jdv.17639
Volume 36, Issue 1 p. e75-e77
Onychomycosis by Candida ciferrii caused fatal multisystemic dissemination in a patient with diabetes mellitus type 2
A. Robles-Tenorio,F.E. Serrano-Ríos,V.M. Tarango-Martínez
doi : 10.1111/jdv.17641
Volume 36, Issue 1 p. e77-e79
